eng Oriental Scientific Publishing Company Biomedical and Pharmacology Journal 0974-6242 2025-12-30 18 4 2933 2939 10.13005/bpj/3306 69354 article Wafaa Mohammed Abdalla 1 Marwa Hussein Abdalgabar 2 Hind Haidar Ahmed 1 Samar Mohammed Saeed 1 Ahmed Bakheeet Abd Alla 1 Tagwa Salah Ahmed 3 Department of Microbiology, College of Medical Laboratory Science , Sudan University of Science and Technology, Khartoum – Sudan. Department of Microbiology, College of Medical laboratory Science, Omdurman Ahlia University, Khartoum- Sudan. Department of Parasitology and Medical Entomology, College of Medical Laboratory Science, Sudan University of Science and Technology, Khartoum – Sudan. Department of Clinical Laboratory Science, College of Applied Medical Science, Jouf University, Saudi Arabia. Fetuses and pregnant women are at risk of serious complications as a result of human parvovirus B19 infection, including non-immune hydrops, intrauterine fetal death, and fetal death. This study was conducted to determine the seroprevalence of Parvovirus B19 immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies among apparently healthy pregnant women and to identify the risk factors associated with B19 infection. Blood samples were collected from consenting pregnant women who were attending antenatal care units in Khartoum state, Sudan, from the period between September 2018 and August 2019.  The enzyme-linked immunosorbent assay (ELISA) technique was used to detect Parvovirus B19 IgG and IgM antibodies in the sera of pregnant women. A structured questionnaire was administered to collect data on sociodemographic characteristics and potential risk factors. A total of 93 pregnant women were enrolled and screened for Parvovirus B19 IgM and IgG antibodies; their ages ranged from 15 to 45 years old. Overall, 8 (8.6%) were positive for Parvovirus B19 IgM antibodies, and 19 (20.4%) had IgG antibodies. Those aged 25-35 years had the highest prevalence of IgM antibodies 7 (7.5%)  and IgG antibodies (13 (14%) there were a  significant relations between B19 IgM, IgG seropositivity and age (p-value = 0.028,0.034) respectively, but no significant association between Parvovirus B19 seropositivity and gravidity, history of blood transfusion, or history of miscarriages  (p>0.05). The prevalence of the B19 virus was low among apparently healthy pregnant women in Khartoum State, Sudan. https://biomedpharmajournal.org/vol18no4/prevalence-of-human-parvovirus-b19-infection-among-apparently-healthy-pregnant-women-attending-selected-antenatal-care-units-khartoum-state-sudan/ ELISA Parvovirus B19 IgG Parvovirus B19 IgM Pregnant Women Sudan